Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KSI-501 by Kodiak Sciences for Diabetic Macular Edema: Likelihood of Approval
KSI-501 is under clinical development by Kodiak Sciences and currently in Phase I for Diabetic Macular Edema. According to GlobalData,...